Prognostic and Predictive Biomarkers in Non-Small Cell Lung Cancer Patients on Immunotherapy—The Role of Liquid Biopsy in Unraveling the Puzzle

SIMPLE SUMMARY: The introduction of immunotherapy modified the cancer treatment landscape, especially for non-small cell lung cancer (NSCLC). Unfortunately, only a subgroup of patients benefits from this therapy. Currently, the only validated companion diagnostic test for first-line immunotherapy in...

Descripción completa

Detalles Bibliográficos
Autores principales: Augustus, Elien, Zwaenepoel, Karen, Siozopoulou, Vasiliki, Raskin, Jo, Jordaens, Stephanie, Baggerman, Geert, Sorber, Laure, Roeyen, Geert, Peeters, Marc, Pauwels, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036384/
https://www.ncbi.nlm.nih.gov/pubmed/33918147
http://dx.doi.org/10.3390/cancers13071675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036384/
https://www.ncbi.nlm.nih.gov/pubmed/33918147
http://dx.doi.org/10.3390/cancers13071675

Ejemplares similares